DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
This Quarter Return
+10.09%
1 Year Return
-2.74%
3 Year Return
+59.83%
5 Year Return
+118.92%
10 Year Return
–
AUM
$390M
AUM Growth
+$390M
(+1.1%)
Cap. Flow
+$11.5M
Cap. Flow
% of AUM
2.95%
Top 10 Holdings %
Top 10 Hldgs %
36.69%
Holding
189
New
3
Increased
23
Reduced
92
Closed
8
Top Buys
| 1 |
Apple
AAPL
|
$21.6M |
| 2 |
UnitedHealth
UNH
|
$8.22M |
| 3 |
Qorvo
QRVO
|
$3.31M |
| 4 |
DexCom
DXCM
|
$292K |
| 5 |
Atlassian
TEAM
|
$229K |
Top Sells
| 1 |
Edwards Lifesciences
EW
|
$9.8M |
| 2 |
Centene
CNC
|
$1.4M |
| 3 |
Amazon
AMZN
|
$756K |
| 4 |
lululemon athletica
LULU
|
$736K |
| 5 |
Pfizer
PFE
|
$716K |
Sector Composition
| 1 | Healthcare | 24.4% |
| 2 | Technology | 24.34% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Communication Services | 8.9% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Pfizer
PFE
$141B
| $4.75M | 1.22% |
129,508
-19,520
| -13% | -$716K |
|
27
American Tower
AMT
$95.5B
| $4.37M | 1.12% |
18,082
+768
| +4% | +$186K |
|
28
Intel
INTC
$107B
| $3.92M | 1.01% |
75,715
-3,419
| -4% | -$177K |
|
29
Eli Lilly
LLY
$657B
| $3.61M | 0.92% |
24,362
-1,175
| -5% | -$174K |
|
30
PepsiCo
PEP
$204B
| $3.47M | 0.89% |
25,029
-1,894
| -7% | -$263K |
|
31
Bristol-Myers Squibb
BMY
$96B
| $3.38M | 0.87% |
56,064
-225
| -0.4% | -$13.6K |
|
|
32
Qorvo
QRVO
$8.4B
| $3.31M | 0.85% |
+25,635
| New | +$3.31M |
|
33
Southern Company
SO
$102B
| $3.01M | 0.77% |
55,454
-2,155
| -4% | -$117K |
|
34
Cisco
CSCO
$274B
| $2.95M | 0.76% |
74,886
-1,610
| -2% | -$63.4K |
|
35
Consolidated Edison
ED
$35.4B
| $2.89M | 0.74% |
37,085
-2,560
| -6% | -$199K |
|
36
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.64M | 0.68% |
12,394
-470
| -4% | -$100K |
|
|
37
DexCom
DXCM
$29.5B
| $2.51M | 0.64% |
6,084
+709
| +13% | +$292K |
|
38
Dominion Energy
D
$51.1B
| $2.46M | 0.63% |
31,199
-1,225
| -4% | -$96.7K |
|
39
Truist Financial
TFC
$60.4B
| $2.41M | 0.62% |
63,356
-5,297
| -8% | -$202K |
|
40
Merck
MRK
$210B
| $2.32M | 0.6% |
27,993
-310
| -1% | -$25.7K |
|
41
Vanguard Growth ETF
VUG
$185B
| $2.14M | 0.55% |
9,412
-214
| -2% | -$48.7K |
|
42
Exxon Mobil
XOM
$487B
| $1.93M | 0.49% |
56,158
-13,939
| -20% | -$479K |
|
43
AT&T
T
$209B
| $1.92M | 0.49% |
67,268
-1,005
| -1% | -$28.7K |
|
44
RGC Resources
RGCO
$230M
| $1.78M | 0.46% |
75,685
-311
| -0.4% | -$7.29K |
|
|
HZNP
45
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.77M | 0.45% |
22,775
| – | – |
|
46
Duke Energy
DUK
$95.3B
| $1.66M | 0.43% |
18,791
-1,532
| -8% | -$136K |
|
47
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $1.65M | 0.42% |
38,101
+1,586
| +4% | +$68.6K |
|
48
Vanguard Real Estate ETF
VNQ
$34.6B
| $1.53M | 0.39% |
19,425
-278
| -1% | -$22K |
|
49
Nuveen Preferred & Income Opportunities Fund
JPC
$2.6B
| $1.53M | 0.39% |
179,700
-10,500
| -6% | -$89.2K |
|
50
Equifax
EFX
$30.3B
| $1.51M | 0.39% |
9,623
| – | – |
|